Company intelligence
Perfuze
Neurovascular medical device company developing technology for Ischemic Stroke
Medical Equipment Manufacturing
Galway, IE
54 employees
Founded 2018
3 public signals
About Perfuze
Perfuze, a Galway-based medical device company, is advancing fast, safe, and predictable stroke treatment through innovation. Backed by the MARRS trial clinical evidence, the Millipede™ System’s unique corrugated design offers best-in-class deliverability and precise vessel matching for superior first-pass success. Combining powerful aspiration with reliable performance, the Perfuze portfolio helps physicians restore blood flow quickly and safely.
Verified activity
Signals from Perfuze
3 published signals
Research & Knowledge
Perfuze achieved first-pass reperfusion success that lifted 90-day functional independence for patients by 17 points, with 60.6% vs. 43.4% compared to Millipede88 delivering first-pass success in 75% of M1 MCA strokes.
Reported by Wayne Allen
Legal & Regulatory
Perfuze announced that the independently adjudicated MARRS study met its primary endpoint and supported FDA clearance of the Millipede88 Super-Bore Catheter for direct aspiration.
Reported by Perfuze
Research & Knowledge
Perfuze completed the MARRS study, which earned Millipede88 its FDA thrombectomy label, with primary endpoint met.
Reported by Wayne Allen